Whether infection of cells by individual virions occurs randomly or if there is some form (s) of competition or cooperativity between individual virions remains largely unknown for most virus-cell ...

We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...

Imunon Inc (IMNN) reports significant progress in its pivotal phase 3 trial for ovarian cancer, while navigating financial ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today noted that our partner, Akeso, Inc. ("Akeso," HKEX Code: 9926.HK) published results from the Phase III HARMONi-A trial, ...